Spero Therapeutics (SPRO) Debt Ratio (2016 - 2024)
Historic Debt Ratio for Spero Therapeutics (SPRO) over the last 9 years, with Q3 2024 value amounting to 0.0.
- Spero Therapeutics' Debt Ratio fell 8338.53% to 0.0 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.0, marking a year-over-year decrease of 8338.53%. This contributed to the annual value of 0.0 for FY2023, which is 3798.9% down from last year.
- Per Spero Therapeutics' latest filing, its Debt Ratio stood at 0.0 for Q3 2024, which was down 8338.53% from 0.0 recorded in Q2 2024.
- Spero Therapeutics' Debt Ratio's 5-year high stood at 0.01 during Q1 2022, with a 5-year trough of 0.0 in Q3 2024.
- Moreover, its 5-year median value for Debt Ratio was 0.0 (2021), whereas its average is 0.0.
- Its Debt Ratio has fluctuated over the past 5 years, first soared by 55749.72% in 2022, then tumbled by 9019.26% in 2023.
- Quarter analysis of 5 years shows Spero Therapeutics' Debt Ratio stood at 0.0 in 2020, then tumbled by 30.06% to 0.0 in 2021, then dropped by 4.64% to 0.0 in 2022, then plummeted by 37.99% to 0.0 in 2023, then plummeted by 79.84% to 0.0 in 2024.
- Its Debt Ratio was 0.0 in Q3 2024, compared to 0.0 in Q2 2024 and 0.0 in Q1 2024.